We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COLD icon
301
Americold
COLD
$4.17B
$960K 0.11%
33,942
-38,250
-53% -$1.09M
CLF icon
302
Cleveland-Cliffs
CLF
$6.99B
$958K 0.11%
74,996
-31,602
-30% -$429K
XENE icon
303
Xenon Pharmaceuticals
XENE
$6.36B
$955K 0.11%
24,265
-5,931
-20% -$239K
AGX icon
304
Argan
AGX
$7.61B
$955K 0.11%
9,412
+5,260
+127% +$416K
VVV icon
305
Valvoline
VVV
$5.05B
$949K 0.11%
+22,679
New +$964K
BLCO icon
306
Bausch + Lomb
BLCO
$5.8B
$945K 0.11%
48,976
+24,864
+103% +$411K
CNXN icon
307
PC Connection
CNXN
$2.05B
$943K 0.11%
12,504
+48
+0.4% +$3.34K
KEYS icon
308
Keysight
KEYS
$53.6B
$940K 0.11%
5,916
-14,580
-71% -$2.08M
PLUS icon
309
ePlus
PLUS
$2.33B
$940K 0.11%
9,554
+743
+8% +$65.4K
NHC icon
310
National Healthcare
NHC
$3.53B
$938K 0.11%
+7,458
New +$938K
PCAR icon
311
PACCAR
PCAR
$70.2B
$937K 0.11%
+9,497
New +$929K
COO icon
312
Cooper Companies
COO
$13.7B
$934K 0.11%
8,461
-3,701
-30% -$360K
OKTA icon
313
Okta
OKTA
$23.9B
$933K 0.11%
+12,552
New +$1.1M
SAH icon
314
Sonic Automotive
SAH
$3.25B
$932K 0.11%
15,936
-228
-1% -$13.1K
PRDO icon
315
Perdoceo Education
PRDO
$1.99B
$932K 0.11%
41,895
+28,763
+219% +$648K
XEL icon
316
Xcel Energy
XEL
$50.4B
$930K 0.11%
14,237
-17,697
-55% -$1.05M
VSAT icon
317
Viasat
VSAT
$10.2B
$926K 0.11%
+77,536
New +$1.25M
SFM icon
318
Sprouts Farmers Market
SFM
$7.23B
$925K 0.11%
8,378
+597
+8% +$56.9K
AHRT
319
AH Realty Trust
AHRT
$536M
$920K 0.11%
84,926
+71,292
+523% +$833K
VC icon
320
Visteon
VC
$2.82B
$920K 0.11%
+9,656
New +$981K
SMG icon
321
ScottsMiracle-Gro
SMG
$4.06B
$906K 0.11%
+10,455
New +$735K
ALRM icon
322
Alarm.com
ALRM
$2.65B
$901K 0.11%
16,472
+6,675
+68% +$410K
SKY icon
323
Champion Homes
SKY
$4.52B
$900K 0.11%
9,492
+4,942
+109% +$414K
MDLZ icon
324
Mondelez International
MDLZ
$77.9B
$900K 0.11%
+12,218
New +$859K
ESE icon
325
ESCO Technologies
ESE
$8.4B
$899K 0.11%
6,973
+1,782
+34% +$210K
11 12
13
14 15

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.